Moderna on Wednesday reported second quarter results that beat earnings and revenue expectations driven $4.5 billion in sales from its COVID -19 vaccine, but it's still the company's only commercially available product and it took a big hit on expiring shots.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
